16:02 Dec 20
Neuland Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Neuland Laboratories Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
79/100
High Financial Strength
Valuation
15/100
Expensive Valuation
Technical
61/100
Technically Moderately Bullish
Strength
11
Weakness
7
Opportunity
1
Threats
1
17.82K
Market Cap (Cr)
63.73
PE Ratio
12.78
Price to Book Ratio
35.04
RSI
19.25 %
Net Profit Margin
Download Our App On:
